MarketPulse

institutional investor

4 articles
The Motley FoolThe Motley Fool··Andy Gould

Major Shareholder Trims $7.8M Harrow Stake, Signals Profit-Taking Over Retreat

Opaleye Management sold $7.8M in $HARR shares while retaining 10% stake, suggesting tactical rebalancing rather than loss of confidence in ophthalmic pharma company.
HROWearnings missportfolio rebalancing
The Motley FoolThe Motley Fool··Will Healy

Major Shareholder Cashes Out $19.4M in Hut 8 Stake Amid Valuation Concerns

Ardsley Advisory Partners sells 440,000 Hut 8 shares (55% stake) worth $19.4M in Q4 2025, citing concerns over 26x price-to-sales valuation despite strong growth.
LLYAVGOHUTFSLRLITE+1cryptocurrencydata centers
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Investor Trims $104M Nuvalent Stake as Cancer Drug Developer Surges 30%

Vestal Point Capital sold $103.93M in Nuvalent shares, reducing exposure despite company's 30% rally and $1.4B cash position awaiting 2026 FDA decisions.
ABBVNUVLTERNBMRNFDA approvalbiotech
The Motley FoolThe Motley Fool··Lawrence Rothman, Cfa

Irenic Capital Significantly Trims Papa John's Stake Amid Market Underperformance

Irenic Capital divests 70% of Papa John's stake due to underperformance, with stock down 30.7% over past year amid broader QSR sector challenges.
ITGRALKTPZZASHCTBPHsame-store sales declineunderperformance